Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LSB Industries | LXU | May 17, 2024 | 9.70 | +5.21 |
LSI Industries | LYTS | May 17, 2024 | 15.85 | +0.38 |
Ltc Properties | LTC | May 17, 2024 | 34.76 | +0.35 |
Lucas GC | LGCL | May 17, 2024 | 3.18 | 0.00 |
Lucid Diagnostics | LUCD | May 17, 2024 | 0.91 | +1.69 |
Lucid Group | LCID | May 17, 2024 | 2.84 | -1.39 |
Lucy Scientific Discovery | LSDI | May 17, 2024 | 1.46 | -8.18 |
Lufax ADR | LU | May 17, 2024 | 4.72 | +3.74 |
Lululemon Athletica | LULU | May 17, 2024 | 334.95 | -0.98 |
Lulus Fashion Lounge | LVLU | May 17, 2024 | 1.74 | -1.14 |
Lumen Technologies | LUMN | May 17, 2024 | 1.32 | +0.76 |
Lument Finance Trust | LFT | May 17, 2024 | 2.48 | -0.80 |
Lument Finance Trust A Pref | LFT-A | May 17, 2024 | 19.20 | -0.05 |
Lumentum | LITE | May 17, 2024 | 46.05 | -1.60 |
Luminar Technologies A | LAZR | May 17, 2024 | 1.72 | -0.58 |
Lumos Pharma | LUMO | May 17, 2024 | 2.54 | -3.42 |
Luna Innovations | LUNA | May 17, 2024 | 3.01 | +2.03 |
Luokung Technology | LKCO | May 17, 2024 | 0.58 | +0.54 |
Luxfer | LXFR | May 17, 2024 | 12.05 | -3.75 |
LuxUrban Hotels | LUXH | May 17, 2024 | 0.50 | +24.68 |
Luxurban Hotels Pref | LUXHP | May 17, 2024 | 19.00 | +0.00 |
Lxp Industrial Trust | LXP | May 17, 2024 | 8.87 | -0.56 |
LXP Industrial Trust C Pref | LXP-C | May 17, 2024 | 45.26 | -0.54 |
Lyell Immunopharma | LYEL | May 17, 2024 | 2.74 | -1.44 |
Lyft A | LYFT | May 17, 2024 | 16.62 | -1.95 |
LyondellBasell Industries Nv A | LYB | May 17, 2024 | 100.91 | +0.97 |
Lyra Therapeutics | LYRA | May 17, 2024 | 0.38 | +4.19 |
Lytus Technologies | LYT | May 17, 2024 | 3.19 | +4.25 |
M&T Bank | MTB | May 17, 2024 | 153.79 | +0.21 |
M&T Bank H Pref | MTB-H | May 17, 2024 | 23.88 | -1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.